MircoRNA-33a inhibits epithelial-to-mesenchymal transition and metastasis and could be a prognostic marker in non-small cell lung cancer.

Scientific Reports
Lihua YangZhaohui Gong

Abstract

Understanding the molecular mechanism by which epithelial mesenchymal transition (EMT)-mediated cancer metastasis and how microRNA (miRNA) regulates lung cancer progression via Twist1-activated EMT may provide potential therapeutic targets for cancer therapy. Here we found that miR-33a, an intronic miRNA located within the sterol regulatory element-binding protein 2 (SREBP-2) gene, is expressed at low levels in metastatic non-small cell lung cancer (NSCLC) cells and is inversely correlated with Twist1 expression. Conversely, miR-33a knockdown induces EMT and miR-33a overexpression blocks EMT by regulating of Twist1 expression in NSCLC cells. Bioinformatical prediction and luciferase reporter assay confirm that Twist1 is a direct target of miR-33a. Additionally, Twist1 knockdown blocks EMT-related metastasis and forced expression of miR-33a inhibits lung cancer metastasis in a xenograft animal model. Clinically, miR-33a is found to be at low levels in NSCLC patients and down-regulation of miR-33a predicts a poor prognosis. These findings suggest that miR-33a targets Twist1 and inhibits invasion and metastasis in NSCLC. Thus, miR-33a might be a potential prognostic marker and of therapeutic relevance for NSCLC metastasis interven...Continue Reading

References

Nov 25, 2005·British Journal of Cancer·A PuisieuxS Ansieau
Sep 26, 2008·The New England Journal of Medicine·Roy S HerbstScott M Lippman
Jun 3, 2009·The Journal of Clinical Investigation·Raghu Kalluri, Robert A Weinberg
Sep 24, 2009·Cancer Research·Douglas R HurstDanny R Welch
Nov 26, 2009·Nature Cell Biology·Ulrich WellnerThomas Brabletz
Apr 13, 2010·Oncogene·S AnsieauA Puisieux
May 15, 2010·Science·S Hani Najafi-ShoushtariAnders M Näär
Jun 23, 2010·Proceedings of the National Academy of Sciences of the United States of America·Tyler J MarquartAngel Baldán
Aug 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Joseph H TaubeSendurai A Mani
Mar 26, 2011·Science·Christine L Chaffer, Robert A Weinberg
Jul 12, 2011·Oncogene·M ThomasR K Hartmann
Oct 26, 2011·The Journal of Cell Biology·Nam Hee KimJong In Yook
Feb 16, 2012·Cell Cycle·Daniel Cirera-SalinasCarlos Fernández-Hernando
Mar 13, 2012·Seminars in Cancer Biology·Neha TiwariGerhard Christofori
Mar 13, 2012·Nature Cell Biology·Wen-Hao YangMuh-Hwa Yang
Jul 19, 2012·Journal of Cancer Research and Clinical Oncology·Zhiwei ZhongZhaohui Gong
Oct 5, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maria T Di MartinoPierfrancesco Tassone
Feb 26, 2013·Current Opinion in Cell Biology·Samy LamouilleRik Derynck
Mar 30, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Zhiwei ZhongZhaohui Gong
Jul 19, 2013·Annals of Surgical Oncology·J M HernandezD Shibata
Aug 26, 2014·Nature Communications·Hsiao-Fan ChenKou-Juey Wu

❮ Previous
Next ❯

Citations

Jan 20, 2016·Journal of Clinical Medicine·Mohammed L AbbaHeike Allgayer
Nov 26, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Qing-Qing ZhuTangfeng Lv
Jan 24, 2016·Cell Biology International·Ying-Jie LiWen Zhang
Oct 27, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·You-Jin LuYing Wang
Jul 29, 2016·Current Osteoporosis Reports·Scott R Baier, Yihong Wan
Dec 9, 2016·PloS One·Ting-Chih YehLing-Ming Tseng
Oct 14, 2017·Briefings in Functional Genomics·Aliaa A AlamoudiHoda Gad
Dec 15, 2017·BMC Pulmonary Medicine·Jorge MoisésRamón María Marrades
Mar 5, 2019·Cellular and Molecular Life Sciences : CMLS·Katharina VestreCinzia Progida
Apr 3, 2019·International Journal of Molecular Sciences·Kuan-Li WuAnd Jen-Yu Hung
Nov 30, 2019·Molecular Oncology·Sara NicolaiGiuseppe Raschellà
Feb 6, 2019·Oncotarget·Yousef G Amaar, Mark E Reeves
Sep 28, 2017·Oncotarget·Omer Faruk KaratasMichael Ittmann
Sep 26, 2020·Frontiers in Oncology·Linyuan XueXiangyan Li
Mar 1, 2019·Cancers·Shang-Gin WuJin-Yuan Shih
Mar 25, 2020·Cancer Cell International·Zeng WeihuaLi Weizhan
Dec 7, 2016·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Q LiB Qiao
Aug 5, 2017·Cancers·Antoine LegrasHélène Blons
Apr 26, 2016·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Zuzana PastorkovaJozef Andel
Apr 7, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Haihua TianZhaohui Gong
Sep 20, 2018·International Journal of Molecular Sciences·Lei DingQinghua Cui
Jun 30, 2021·Journal of Colloid and Interface Science·Qingsheng PengLingmin Zhang

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
transfection
surgical resection
PCR
scraping

Software Mentioned

TargetScan
Graphpad Prism

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.